Bioactive Wound Dressing With Sensor-Guided Antimicrobial Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing honey-based wound dressings lack sustained and intelligent therapeutic delivery, failing to adapt to wound progression stages or patient-specific responses, leading to inconsistent healing and potential microbial resistance, and are not integrated with clinical environments for real-time monitoring and feedback.
Innovation Solution
A multi-layered bioactive wound dressing device incorporating honey bee-derived components with microencapsulated structures, embedded sensors, and programmable actuators for controlled release, integrating biosensors and machine learning to dynamically respond to wound conditions and clinical context.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional honey-based dressings are used, then immediate antimicrobial protection is provided, but therapeutic delivery is not sustained and requires frequent dressing changes
Solution Approach 1:
The dressing is divided into multiple microencapsulated units containing honey and bee by-products, distributed throughout a porous matrix. This segmentation allows sustained release over time without requiring frequent complete replacements, addressing the contradiction between duration of protection and frequency of changes.
Solution Approach 2:
The honey and therapeutic agents are pre-encapsulated within the matrix structure during manufacturing, positioning them for controlled release. This preliminary preparation enables sustained therapeutic delivery throughout the wound healing period, reducing the need for frequent dressing changes.
2Adaptability or versatility
If static applications of honey are used, then simple application is maintained, but adaptability to wound progression stages is lost
Solution Approach 1:
The dressing incorporates a porous matrix with controlled porosity that dynamically adjusts to wound conditions. The matrix structure allows adaptive release of therapeutic agents based on wound progression, providing versatility while maintaining a relatively simple overall design through natural material properties.
Solution Approach 2:
The physical and chemical parameters of the matrix (porosity, hydrophilicity) are optimized to enable adaptive release kinetics. These parameter changes allow the system to respond to varying wound conditions without requiring complex active control mechanisms, balancing adaptability with simplicity.
3Manufacturing precision
If microencapsulated structures are integrated, then controlled release is achieved, but manufacturing complexity increases
Solution Approach 1:
A porous matrix material is used as the foundation for the dressing, providing inherent structural complexity that enables controlled release. The porosity of the matrix naturally facilitates diffusion and release kinetics without requiring additional complex microencapsulation steps, simplifying manufacturing while maintaining precision.
Solution Approach 2:
The microencapsulated honey units are integrated directly into the porous matrix structure during a single manufacturing process. This merging of functions (encapsulation and matrix structure) reduces the number of separate manufacturing steps, making the process more straightforward while achieving precise release control.
4Measurement precision
If intelligent monitoring components are added, then real-time feedback is provided, but device complexity increases
Solution Approach 1:
Sensors are integrated into the dressing to provide real-time feedback on wound conditions such as pH, temperature, and moisture. This feedback mechanism enables precise monitoring of wound healing progress while the modular sensor design keeps the overall system complexity manageable by providing only essential measurements.
Solution Approach 2:
The monitoring sensors are designed with multi-functionality, serving both as measurement devices and as part of the therapeutic delivery system. This universal design reduces the number of separate components needed, thereby limiting the increase in device complexity while maintaining precise monitoring capabilities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device provides precise, patient-specific care by adapting therapeutic release to wound dynamics, reducing treatment errors, and enhancing healing efficacy through intelligent monitoring and feedback, suitable for diverse healthcare settings.
Implementation Method 1
microencapsulated structures, embedded sensors, and programmable actuators for controlled release
Implementation Method 2
embedded sensors, integrating biosensors and machine learning to dynamically respond to wound conditions
Data Source
AI summary
The present invention discloses an intelligent, bioengineered wound dressing device that utilizes honey bee-derived therapeutic compounds integrated into a programmable, multi-layered delivery structure designed for sustained antimicrobial release and dynamic wound healing modulation. The device features microencapsulated honey, propolis, and beeswax components embedded within a biocompatible hydrogel matrix, supported by a control technique that processes real-time wound data acquired through embedded biosensors. The technique classifies healing phases, detects wound anomalies, and modulates therapeutic release through actuators based on environmental cues such as pH, temperature, and exudate levels. The system further includes a logic control unit capable of adaptive learning, remote data transmission, and wound trajectory logging, ensuring precise, patient-specific therapeutic delivery. By integrating natural antimicrobial agents with intelligent sensing and release architectures, the invention provides a responsive, self-optimizing wound care platform that enhances healing outcomes, reduces dressing intervention frequency, and improves clinical oversight through real-time therapeutic intelligence.